BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palacios-Rápalo SN, De Jesús-González LA, Cordero-Rivera CD, Farfan-Morales CN, Osuna-Ramos JF, Martínez-Mier G, Quistián-Galván J, Muñoz-Pérez A, Bernal-Dolores V, Del Ángel RM, Reyes-Ruiz JM. Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry. Front Immunol 2021;12:796855. [PMID: 34975904 DOI: 10.3389/fimmu.2021.796855] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Milusev A, Despont A, Shaw J, Rieben R, Sorvillo N. Inflammatory stimuli induce shedding of heparan sulfate from arterial but not venous porcine endothelial cells leading to differential proinflammatory and procoagulant responses. Sci Rep 2023;13:4483. [PMID: 36934164 DOI: 10.1038/s41598-023-31396-z] [Reference Citation Analysis]
2 Vymazalová K, Šerý O, Králík P, Dziedzinská R, Musilová Z, Frišhons J, Vojtíšek T, Joukal M. Substantial decrease in SARS-CoV-2 RNA after fixation of cadavers intended for anatomical dissection. Anat Sci Int 2023;:1-7. [PMID: 36869879 DOI: 10.1007/s12565-023-00707-9] [Reference Citation Analysis]
3 Reyes-Ruiz JM, Manrique-Calvillo C, Martínez-Mier G, Servin-Monroy AO, Mota-García G, DE Maria Lugo-Miranda F, Villegas-Del Angel E, Zarate-Segura P, Bastida-Gonzalez F, Del Angel RM. Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I. In Vivo 2023;37:933-9. [PMID: 36881093 DOI: 10.21873/invivo.13165] [Reference Citation Analysis]
4 Moon B, Ahn D, Park J, Mai TQN, Batjargal U, Hong H, Yoon S, Lee S, Yoon GY, Kim C, Ku KB, Nam HJ, Kwak I, Kim S, Cho H. Brain corticogenesis and cholesterol homeostasis promotes SARS-CoV-2 infection and replication.. [DOI: 10.21203/rs.3.rs-2481841/v1] [Reference Citation Analysis]
5 Abou-Hamdan M, Saleh R, Mani S, Dournaud P, Metifiot M, Blondot ML, Andreola ML, Abdel-Sater F, De Reggi M, Gressens P, Laforge M. Potential antiviral effects of pantethine against SARS-CoV-2. Sci Rep 2023;13:2237. [PMID: 36754974 DOI: 10.1038/s41598-023-29245-0] [Reference Citation Analysis]
6 Crook H, Ramirez A, Hosseini AA, Vavougyios G, Lehmann C, Bruchfeld J, Schneider A, d'Avossa G, Lo Re V, Salmoiraghi A, Mukaetova-Ladinska E, Katshu M, Boneschi FM, Håkansson K, Geerlings M, Pracht E, Ruiz A, Jansen JF, Snyder H, Kivipelto M, Edison P. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. Brain Connect 2023. [PMID: 36719785 DOI: 10.1089/brain.2022.0058] [Reference Citation Analysis]
7 Cumhur Cure M, Cure E. Severe acute respiratory syndrome coronavirus 2 may cause liver injury via Na+/H+ exchanger. World J Virol 2023; 12(1): 12-21 [DOI: 10.5501/wjv.v12.i1.12] [Reference Citation Analysis]
8 Fantini J, Chahinian H, Yahi N. Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future. Int J Mol Sci 2023;24. [PMID: 36768244 DOI: 10.3390/ijms24031923] [Reference Citation Analysis]
9 Thangavel H, Dhanyalayam D, Lizardo K, Oswal N, Dolgov E, Perlin DS, Nagajyothi JF. Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model. Int J Mol Sci 2023;24. [PMID: 36674830 DOI: 10.3390/ijms24021314] [Reference Citation Analysis]
10 Kim TY, Jeon S, Ko M, Du YE, Son SR, Jang DS, Kim S, Lee CJ. Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern. Antimicrob Agents Chemother 2022;66:e0120122. [PMID: 36374087 DOI: 10.1128/aac.01201-22] [Reference Citation Analysis]
11 Zhou YQ, Wang K, Wang XY, Cui HY, Zhao Y, Zhu P, Chen ZN. SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner. Emerg Microbes Infect 2022;11:1135-44. [PMID: 35343395 DOI: 10.1080/22221751.2022.2059403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Alboni S, Secco V, Papotti B, Vilella A, Adorni MP, Zimetti F, Schaeffer L, Tascedda F, Zoli M, Leblanc P, Villa E. Hydroxypropyl-β-Cyclodextrin depletes membrane cholesterol and inhibits SARS-COV-2 entry into HEK293T-ACEhi cells.. [DOI: 10.21203/rs.3.rs-2223656/v1] [Reference Citation Analysis]
13 Zhang S, Tong Y. Advances in the previous two decades in our understanding of the post-translational modifications, functions, and drug perspectives of ArgBP2 and its family members. Biomedicine & Pharmacotherapy 2022;155:113853. [DOI: 10.1016/j.biopha.2022.113853] [Reference Citation Analysis]
14 Laplantine E, Chable-Bessia C, Oudin A, Swain J, Soria A, Merida P, Gourdelier M, Mestiri S, Besseghe I, Bremaud E, Neyret A, Lyonnais S, Favard C, Benaroch P, Hubert M, Schwartz O, Guerin M, Danckaert A, Del Nery E, Muriaux D, Weil R. The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling. iScience 2022;25:105066. [PMID: 36093378 DOI: 10.1016/j.isci.2022.105066] [Reference Citation Analysis]
15 Mégarbane B. Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful? J Pers Med 2022;12:1627. [PMID: 36294766 DOI: 10.3390/jpm12101627] [Reference Citation Analysis]
16 Zhao Y, Jaber VR, Lukiw WJ. SARS-CoV-2, long COVID, prion disease and neurodegeneration. Front Neurosci 2022;16:1002770. [DOI: 10.3389/fnins.2022.1002770] [Reference Citation Analysis]
17 Stadler JT, Mangge H, Rani A, Curcic P, Herrmann M, Prüller F, Marsche G. Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19. Antioxidants 2022;11:1858. [DOI: 10.3390/antiox11101858] [Reference Citation Analysis]
18 Schieffer E, Schieffer B. The rationale for the treatment of long-Covid symptoms – A cardiologist's view. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.992686] [Reference Citation Analysis]
19 Lukiw WJ, Jaber VR, Pogue AI, Zhao Y. SARS-CoV-2 Invasion and Pathological Links to Prion Disease. Biomolecules 2022;12. [PMID: 36139092 DOI: 10.3390/biom12091253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Fiore D, Proto MC, Franceschelli S, Pascale M, Bifulco M, Gazzerro P. In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks. Biomedicines 2022;10:2123. [DOI: 10.3390/biomedicines10092123] [Reference Citation Analysis]
21 Grajeda BI, De Chatterjee A, Villalobos CM, Pence BC, Ellis CC, Enriquez V, Roy S, Roychowdhury S, Neumann AK, Almeida IC, Patterson SE, Das S. Giardial lipid rafts share virulence factors with secreted vesicles and participate in parasitic infection in mice. Front Cell Infect Microbiol 2022;12:974200. [DOI: 10.3389/fcimb.2022.974200] [Reference Citation Analysis]
22 Bakillah A, Hejji FA, Almasaud A, Jami HA, Hawwari A, Qarni AA, Iqbal J, Alharbi NK. Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells. Nutrients 2022;14:3417. [PMID: 36014919 DOI: 10.3390/nu14163417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther 2022;7:265. [PMID: 35918332 DOI: 10.1038/s41392-022-01125-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Chidambaram V, Kumar A, Majella MG, Seth B, Sivakumar RK, Voruganti D, Bavineni M, Baghal A, Gates K, Kumari A, Al'Aref SJ, Galiatsatos P, Karakousis PC, Mehta JL. HDL cholesterol levels and susceptibility to COVID-19. EBioMedicine 2022;82:104166. [PMID: 35843172 DOI: 10.1016/j.ebiom.2022.104166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Han H, Wang Y, Xu S, Han C, Qin Q, Wei S. High-density lipoproteins negatively regulate innate immunity and facilitate red-spotted grouper nervous necrosis virus entry via scavenger receptor B type 1. Int J Biol Macromol 2022;215:424-33. [PMID: 35752331 DOI: 10.1016/j.ijbiomac.2022.06.126] [Reference Citation Analysis]
26 Zhao Y, Lukiw WJ. SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease. Front Cell Neurosci 2022;16:937961. [DOI: 10.3389/fncel.2022.937961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mosaad YO, Baraka MA, Warda AEA, Ateyya H, Hussein MA, Gaber S. Plasma lipid profile: a predictive marker of disease severity among COVID-19 patients—an opportunity for low-income countries. Drugs Ther Perspect 2022;38:286-291. [DOI: 10.1007/s40267-022-00916-8] [Reference Citation Analysis]
28 Kalejaiye TD, Bhattacharya R, Burt MA, Travieso T, Okafor AE, Mou X, Blasi M, Musah S. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes. Front Cell Dev Biol 2022;10:855340. [DOI: 10.3389/fcell.2022.855340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
29 Schmidt NM, Wing PA, Peters R, Brown R, Wang H, Swadling L, Newman J, Thakur N, Shionoya K, Morgan SB, Hinks TS, Watashi K, Bailey D, Hansen SB, Maini MK, Mckeating JA, COVIDsortium Investigators. An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity.. [DOI: 10.1101/2022.04.12.487988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Teixeira L, Temerozo JR, Pereira-dutra FS, Ferreira AC, Mattos M, Gonçalves BS, Sacramento CQ, Palhinha L, Cunha-fernandes T, Dias SSG, Soares VC, Barreto EA, Cesar-silva D, Fintelman-rodrigues N, Pão CRR, de Freitas CS, Reis PA, Hottz ED, Bozza FA, Bou-habib DC, Saraiva EM, de Almeida CJG, Viola JPB, Souza TML, Bozza PT. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts. Front Immunol 2022;13:820131. [DOI: 10.3389/fimmu.2022.820131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
31 Ding B, Yu Y, Geng S, Liu B, Hao Y, Liang G. Computational Methods for the Interaction between Cyclodextrins and Natural Compounds: Technology, Benefits, Limitations, and Trends. J Agric Food Chem 2022. [PMID: 35170315 DOI: 10.1021/acs.jafc.1c07018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Tanase A, Manea A, Scurtu AD, Bratu LM, Chioran D, Dolghi A, Alexoi I, Aabed H, Lazureanu V, Dehelean CA. The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment. Medicina 2022;58:261. [DOI: 10.3390/medicina58020261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bianconi V, Cosentini E, Mannarino MR, Pirro M. Risk Factors of Developing COVID-19 and its Severe Course. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_4] [Reference Citation Analysis]
34 Crozier TWM, Greenwood EJD, Williamson JC, Guo W, Porter LM, Gabaev I, Teixeira-Silva A, Grice GL, Wickenhagen A, Stanton RJ, Wang ECY, Wilson SJ, Matheson NJ, Nathan JA, McCaughan F, Lehner PJ. Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasion. Wellcome Open Res 2022;7:224. [PMID: 36483314 DOI: 10.12688/wellcomeopenres.17946.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Park HJ, Jung JH, Han K, Shin J, Lee Y, Chang Y, Park K, Cho YJ, Choi YS, Kim SM, Nam GE. Association between metabolic syndrome and mortality in patients with COVID-19: A nationwide cohort study. Obes Res Clin Pract 2022;16:484-90. [PMID: 36335025 DOI: 10.1016/j.orcp.2022.10.011] [Reference Citation Analysis]